دورية أكاديمية
أعرض في EDS

Diagnostic capacity for cutaneous fungal diseases in the African continent.

التفاصيل البيبلوغرافية
العنوان: Diagnostic capacity for cutaneous fungal diseases in the African continent.
المؤلفون: Badiane AS; Cheikh Anta Diop University of Dakar, Aristide Le Dantec Hospital, Dakar, Senegal., Ramarozatovo LS; USFR Dermatologie-Rhumatologie, de ahead of Dermatologie, Hôpital Universitaire JRB Antananarivo, Antananarivo, Madagascar., Doumbo SN; Department of Epidemiology in Parasitic Diseases, University of Science, Techniques and Technologies of Bamako, Bamako, Mali., Dorkenoo AM; Département des Sciences Biologiques et Fondamentales, Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo., Mandengue C; Dermatology Unit, Université des Montagnes, Bangangté, Cameroon., Dunaisk CM; Health Sciences, Namibia University of Science and Technology, Windhoek, Namibia., Ball M; The Faculty of Medicine at the University of Nouakchott and Ministry of Health, Nouakchott, Mauritania., Dia MK; The Faculty of Medicine at the University of Nouakchott and Ministry of Health, Nouakchott, Mauritania., Ngaya GSL; Institute Pasteur, Bangui, Central African Republic., Mahamat HH; L'Association des Vétérinaires Africains (Rég. Afrique Centrale), N'Djamena, Chad., Kalombo H; Direction des Laboratoires de Santé, Ministère de la Santé Publique, Hygiène et Prévention, Kinshasa, Democratic Republic of Congo (DRC)., Bah A; Medical Research Council (MRC) Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia., Cá Z; Guinea Bissau National Health Center (CENAS), Bissau, Guinea Bissau., Langa JC; Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique., Mohamed AM; National Public Health Reference Laboratory, Ministry of Health, Mogadishu, Somalia., Mokomane M; University of Botswana, Gaborone, Botswana., Ahmed SA; Center of Expertise in Mycology Radboudumc, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Rapalanoro Rabenja F; USFR Dermatologie-Rhumatologie, de ahead of Dermatologie, Hôpital Universitaire JRB Antananarivo, Antananarivo, Madagascar., Hay RJ; King's College, London, UK., Penney ROS; Global Action For Fungal Infections (GAFFI), Geneva, Switzerland., Orefuwa E; Global Action For Fungal Infections (GAFFI), Geneva, Switzerland., Denning DW; Global Action For Fungal Infections (GAFFI), Geneva, Switzerland.; Manchester Fungal Infection Group, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
المصدر: International journal of dermatology [Int J Dermatol] 2023 Sep; Vol. 62 (9), pp. 1131-1141. Date of Electronic Publication: 2023 Jun 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Blackwell Science
Original Publication: Philadelphia, Lippincott.
مواضيع طبية MeSH: Malaria* , HIV Infections* , Dermatomycoses*/diagnosis, Humans ; Africa ; Private Sector
مستخلص: Background: Cutaneous fungal infections are very common, especially in poorer communities and with intercurrent HIV infection. Determining the fungal pathogen in skin-related fungal neglected tropical diseases (NTDs) determines optimal therapy. We undertook a country survey across many African countries to determine the diagnostic capacity for skin fungal diseases.
Methods: A detailed questionnaire was delivered to country contacts to collect data on availability, frequency, and location of testing for key diagnostic procedures and followed up with 2 rounds of validation by video call and by confirmation of individual country data confirmation by email.
Results: Of 47 countries with data, seven (15%) and 21 (45%) do not offer skin biopsy in the public or private sector, respectively, but 22 (46%) countries do it regularly, mostly in university hospitals. Direct microscopy is often performed in 20 of 48 (42%) countries in the public sector and not done in 10 (21%). Fungal cultures are often performed in 21 of 48 (44%) countries in the public sector but not done in nine (20%) or 21 (44%) in either public or private facilities. Histopathological examination of tissue is frequently used in 19 of 48 (40%) countries but not in nine (20%) countries in the public sector. The cost of diagnostics to patients was a major limiting factor in usage.
Conclusion: Major improvements in the availability and use of diagnostic tests for skin, hair, and nail fungal disease are urgently needed across Africa.
(© 2023 The Authors. International Journal of Dermatology published by Wiley Periodicals LLC on behalf of the International Society of Dermatology.)
References: The State of Universal Health Coverage in Africa. Executive summary report of the Africa health agenda. International Conference. 2021 commission. https://ahaic.org/download/the-state-of-universal-health-coverage-in-africa/. Accessed 23 January 2023.
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527-34.
Chandenier J, Desoubeaux G. La transition épidémiologique des mycoses en Afrique subsaharienne: de la surface vers la profondeur. Bull Soc Pathol Exot. 2015;108:41-5.
Coulibaly O, L'Ollivier C, Piarroux R, Ranque S. Epidemiology of human dermatophytoses in Africa. Med Mycol. 2017;56(2):1-17.
Bongomin F, Olum R, Nsenga L, Namusobya M, Russell L, de Sousa E, et al. Estimation of the burden of tinea capitis among children in Africa. Mycoses. 2021;64(4):349-63.
Urban K, Chu S, Scheufele C, Giesey RL, Mehrmal S, Uppal P, Delost GR. The Global, regional and national burden of fungal skin diseases in 195 countries and territories: a cross sectional analysis from the Global Burden of Disease Study. JAAD Int. 2020;2:22-7.
Samuel TO, Adekunle AA, Ogundipe OT. Prevalence of dermatomycoses in tertiary health institutions in Lagos State, Nigeria. J Public Health Epidemiol. 2013;5:101-9.
Contet-audonneau N, Grosjean P, Razanakolona LR, Andriantsinjovina T, Rapelanoro R. Tinea capitis in Madagascar: a survey in a primary school in Antsirabe. Ann Dermatol Venereol. 2006;133:22-5.
Dlova NC, Chateau A, Khoza N, Skenjane A, Mkhize Z, Katibi OS, et al. Prevalence of skin diseases treated at public referral hospitals in KwaZulu-Natal, South Africa. Br J Dermatol. 2018;178:e1-2.
Zidaa A, Sawadogo PM, Diallo I, Tapsoba H, Bazie Z, Drabo YJ, et al. Aspects épidémiologiques des mycoses cutanéo-phanériennes chez les patients infectés par le VIH au Centre national de référence du Burkina Faso, Afrique de l'Ouest. JMycmed. 2016;26(2):133-7.
Denning DW, Perlin DS, Muldoon EG, Colombo AL, Chakrabarti A, Richardson MD, et al. Delivering on the antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities. Emerg Infect Dis. 2017;23:177-83.
Mosam A, Todd G. Dermatology training in Africa: successes and challenges. Dermatol Clin. 2021;39(1):57-71.
World Bank. Current expenditure (% GDP) - Sub-Saharan Africa. New York: World Bank. https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=ZG. Accessed 6 March 2023.
Richard V. Le Financement de la santé en Afrique sub-saharienne le recouvrement des coûts. Med Trop. 2004;64:337-40.
www.naturalearthdata.com. Accessed 18 August 2022.
https://www.cia.gov/the-world-factbook/. Accessed 13 April 2022.
Country burden of disease estimates. https://gaffi.org/media/country-fungal-disease-burdens/. Accessed 4 April 2023.
Aissat FZ, Denning DW. Fungal infections in Algeria. Mycoses. 2023;66(7):594-603.
Badiane AS, Ndiaye D, Denning DW. Burden of serious fungal infection in Senegal. Mycoses. 2015;58(Suppl S5):63-9.
Bissek AC, Tabah EN, Kouotou E, Sini V, Yepnjio FN, Nditanchou R, et al. The spectrum of skin diseases in a rural setting in Cameroon (sub-Saharan Africa). BMC Dermatol. 2012;12:7.
Emery D, Denning DW. The global distribution of actinomycetoma and eumycetoma. PLoS Negl Trop Dis. 2020;14(9):e0008397.
Oladele RO, Ly F, Sow D, Akinkugbe AO, Ocansey BK, Fahal AH, et al. Mycetoma in West Africa. Trans R Soc Trop Med Hyg. 2021;115(4):328-36.
Badiane AS, Ndiaye M, Diongue K, Diallo MA, Seck MC, Ndiaye D. Geographical distribution of mycetoma cases in Senegal over a period of 18 years. Mycoses. 2020;63(3):250-6.
Kwizera R, Bongomin F, Meya DB, Denning DW, Fahal AH, Lukande R. Mycetoma in Uganda: a neglected tropical disease. PLoS Negl Trop Dis. 2020;14(4):e0008240.
Osman M, Kasir D, Rafei R, Kassem II, Ismail MB, El Omari K, et al. Trends in the epidemiology of dermatophytosis in the Middle East and North Africa region. Int J Dermatol. 2022;61(8):935-68.
Eba M, Njunda AL, Mouliom RN, Kwenti ET, Fuh AN, Nchanji GT, et al. Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns. BMC Res Notes. 2016;9(1):494.
Rasamoelina T, Maubon D, Andrianarison M, Ranaivo I, Sendrasoa F, Rakotozandrindrainy N, et al. Endemic chromoblastomycosis caused predominantly by Fonsecaea nubica, Madagascar. Emerg Infect Dis. 2020;26(6):1201-11.
Govender NP, Maphanga TG, Zulu TG, Patel J, Walaza S, Jacobs C, et al. An outbreak of lymphocutaneous sporotrichosis among mine-workers in South Africa. PLoS Negl Trop Dis. 2015;9(9):e0004096.
Rasamoelina T, Maubon D, Raharolahy O, Razanakoto H, Rakotozandrindrainy N, Rakotomalala FA, et al. Sporotrichosis in the highlands of Madagascar, 2013-20171. Emerg Infect Dis. 2019;25(10):1893-902.
Ahmed SA, El-Sobky TA, de Hoog S, Zaki SM, Taha M. A scoping review of mycetoma profile in Egypt: revisiting the global endemicity map. Trans R Soc Trop Med Hyg. 2023;117:1-11.
Elston DM, Stratman EJ, Miller SJ. Skin biopsy: biopsy issues in specific diseases. J Am Acad Dermatol. 2016;74:1-16.
Miller JM, Binnicker MJ, Campbell S, Carroll KC, Chapin KC, Gilligan PH, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1-e94.
Jacquemot P. Les systèmes de santé en Afrique et l'inégalité face aux soins. Afr Contemp. 2012;243:95-7.
Oladele RO, Akase IE, Fahal AH, Govender NP, Hoenigl M, Gangneux JP, et al. Bridging the knowledge gap on mycoses in Africa: setting up a Pan-African Mycology Working Group. Mycoses. 2020;63(3):244-9.
Rambau PF. Pathology practice in a resource-poor setting: Mwanza, Tanzania. Arch Pathol Lab Med. 2011;135(2):191-3.
Gupta AK, Venkataraman M, Hall DC, Cooper EA, Summerbell RC. The emergence of Trichophyton indotineae: implications for clinical practice. Int J Dermatol. 2022;62(7):857-61.
Gupta AK, Renaud HJ, Quinlan EM, Shear NH, Piguet V. The growing problem of antifungal resistance in onychomycosis and other superficial mycoses. Am J Clin Dermatol. 2021;22(2):149-57.
Arendrup MC, Kahlmeter G, Guinea J, Meletiadis J, Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton. Clin Microbiol Infect. 2021;27(1):55-60.
Ending the neglect to attain the sustainable development goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases. https://www.who.int/publications/i/item/9789240051423. Accessed 31 July 2022.
معلومات مُعتمدة: Global Action For Fungi Infections (GAFFI)
تواريخ الأحداث: Date Created: 20230621 Date Completed: 20230822 Latest Revision: 20230822
رمز التحديث: 20230822
DOI: 10.1111/ijd.16751
PMID: 37340531
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-4632
DOI:10.1111/ijd.16751